Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
205.7 EUR | -4.33% | -0.96% | -14.11% |
May. 16 | Sartorius sinks again towards year low | DP |
May. 16 | Transcript : Sartorius Stedim Biotech S.A., Sartorius Aktiengesellschaft - Analyst/Investor Day |
Sales 2024 * | 2.94B 3.2B | Sales 2025 * | 3.35B 3.64B | Capitalization | 20.02B 21.76B |
---|---|---|---|---|---|
Net income 2024 * | 343M 373M | Net income 2025 * | 459M 499M | EV / Sales 2024 * | 7.58 x |
Net Debt 2024 * | 2.27B 2.46B | Net Debt 2025 * | 2.15B 2.34B | EV / Sales 2025 * | 6.62 x |
P/E ratio 2024 * |
57
x | P/E ratio 2025 * |
41.1
x | Employees | 10,493 |
Yield 2024 * |
0.36% | Yield 2025 * |
0.54% | Free-Float | 31.97% |
Latest transcript on Sartorius Stedim Biotech
1 day | -4.33% | ||
1 week | +0.64% | ||
Current month | +1.33% | ||
1 month | -19.21% | ||
3 months | -15.83% | ||
6 months | +2.49% | ||
Current year | -14.11% |
Managers | Title | Age | Since |
---|---|---|---|
René Fáber
CEO | Chief Executive Officer | 48 | 19-03-25 |
Chairman | 59 | 07-06-28 | |
Chief Tech/Sci/R&D Officer | 59 | 09-04-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Henri Riey
BRD | Director/Board Member | 62 | 07-06-28 |
Chairman | 59 | 07-06-28 | |
Susan Dexter
BRD | Director/Board Member | 67 | 15-04-06 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.42% | 17 M€ | +7.35% | - | |
0.35% | 5 M€ | +4.56% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-16 | 205.7 | -4.33% | 175,718 |
24-05-15 | 215 | +2.63% | 62,255 |
24-05-14 | 209.5 | +2.90% | 94,483 |
24-05-13 | 203.6 | -1.02% | 55,956 |
24-05-10 | 205.7 | -0.96% | 60,131 |
Real-time Euronext Paris, May 16, 2024 at 11:35 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.11% | 22.74B | |
-4.72% | 182B | |
+3.96% | 112B | |
-2.93% | 68.58B | |
+6.30% | 51.58B | |
+8.02% | 44.24B | |
+9.45% | 43.65B | |
+26.18% | 32.46B | |
+20.94% | 25.99B | |
+0.57% | 25.61B |
- Stock Market
- Equities
- DIM Stock